The Cancer Research Institute has issued a request for applications for its Clinical Innovator program. This program funds innovative phase I/II or phase II clinical studies with a strong emphasis on:
- Novel immunotherapy approaches
- Mechanistic investigations into clinical response
- The discovery and/or validation of predictive biomarkers
Up to $1,000,000 direct costs, plus up to 10% indirect costs, will be awarded.
To Apply:
- This is an open RFP (UCSF may submit an unlimited number of applications).
- Follow application instructions in RFP, conferring with your Grants Officer as needed. Please notify your Grants Officer of your intention to apply as soon as possible to ensure that they will have enough time to support your application.
- Initial Protocol Concept deadline is December 1, 2025. If you are invited to submit a full application, the due date will be April 4, 2026.
For more information and to review complete application instructions and eligibility requirements, please visit https://www.cancerresearch.org/clinical-innovator.
Due Date